Literature DB >> 21247242

Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years.

Chun-Hou Liao1, Hung-Yuan Li, Shiu-Dong Chung, Han-Sun Chiang, Hong-Jeng Yu.   

Abstract

INTRODUCTION: We evaluated the association between serum sex hormone levels and prostate volume in Taiwanese men.
METHODS: A cross-sectional study was conducted in 505 men (aged 40-79 years, mean age 58 years). Serum total testosterone (TT), free testosterone (FT), dihydrotestosterone (DHT) and estradiol (E2) levels were measured. Total prostate volume (TPV) and transition zone volume (TZV) were measured by transrectal ultrasonography. Body mass index (BMI), DHT/TT and E2/TT were calculated. Correlations were determined using univariate and multivariate regression analyses.
RESULTS: Apart from DHT, an age-dependent change of sex hormone levels were observed. On univariate analyses, age, BMI, serum DHT level and DHT/TT ratio, as well as serum E2 level and E2/TT ratio, but not serum TT and FT levels showed a significant association with prostate volume. On multivariate analysis, however, only serum DHT level and DHT/TT ratio remained significant. Logistic regression analysis showed that the odds ratios (95% confidence interval) of the second, third, and fourth quartiles of serum DHT levels for benign prostatic hyperplasia (defined as TPV ≥ 20 ml) risk were 2.06 (1.21-3.51), 2.66(1.56-4.53) and 7.15(4.0-12.6), respectively (p < 0.001).
CONCLUSIONS: Higher serum DHT level and DHT/TT ratio were associated with larger prostate volume and higher prevalence of BPH in Taiwanese men.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21247242     DOI: 10.3109/13685538.2010.550660

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  11 in total

1.  Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study.

Authors:  Peng Zhang; Wan-Li Hu; Bei Cheng; Yang-Jun Zeng; Xing-Huan Wang; Tong-Zu Liu; Wei-Bing Zhang
Journal:  Int Urol Nephrol       Date:  2015-12-19       Impact factor: 2.370

2.  Inhibitory effects of Hydrocotyle ramiflora on testosterone-induced benign prostatic hyperplasia in rats.

Authors:  Suyoung Park; Youn-Hwan Hwang; Eun-Bok Baek; Eun-Ju Hong; Young-Suk Won; Hyo-Jung Kwun
Journal:  Int Urol Nephrol       Date:  2022-09-15       Impact factor: 2.266

Review 3.  Personalized medicine for the management of benign prostatic hyperplasia.

Authors:  Seth K Bechis; Alexander G Otsetov; Rongbin Ge; Aria F Olumi
Journal:  J Urol       Date:  2014-02-25       Impact factor: 7.450

4.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01

Review 5.  Androgen receptor roles in the development of benign prostate hyperplasia.

Authors:  Kouji Izumi; Atsushi Mizokami; Wen-Jye Lin; Kuo-Pao Lai; Chawnshang Chang
Journal:  Am J Pathol       Date:  2013-04-06       Impact factor: 4.307

6.  Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk.

Authors:  Jian-Qin Zhang; Hui Geng; Mao Ma; Xun-Yi Nan; Bin-Wu Sheng
Journal:  Med Sci Monit       Date:  2015-08-14

Review 7.  Sex steroids and cardiovascular disease.

Authors:  Bu Beng Yeap
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

8.  Inhibitory Effect of Yongdamsagan-Tang Water Extract, a Traditional Herbal Formula, on Testosterone-Induced Benign Prostatic Hyperplasia in Rats.

Authors:  Eunsook Park; Mee-Young Lee; Woo-Young Jeon; Nari Lee; Chang-Seob Seo; Hyeun-Kyoo Shin
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-18       Impact factor: 2.629

9.  Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials.

Authors:  Changcheng Guo; Wenyu Gu; Min Liu; B O Peng; Xudong Yao; Bin Yang; Junhua Zheng
Journal:  Exp Ther Med       Date:  2015-12-23       Impact factor: 2.447

Review 10.  Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?

Authors:  Bing-Juin Chiang; Hann-Chorng Kuo; Chun-Hou Liao
Journal:  Toxins (Basel)       Date:  2019-09-19       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.